You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › October › 10
Drugmaker
9 months ago
Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash.
page 1 of 1